STero aims to determine if CBD, the non-psychoactive component in cannabis, can enhance the effect of corticosteroids — the first line of treatment for autoimmune illnesses like inflammatory bowel disease and lupus — or enable reducing steroid dosage while maintaining or improving its therapeutic effects.
Stero has a broad US patent covering 130 autoimmune and inflammatory diseases, including Crohn’s disease, hepatitis, arthritis and chronic urticaria (hives).
“The patent covers botanic and synthetically produced CBD, at any dosage and in combination with other drugs,”
Read more: https://www.israel21c.org/cbd-may-improve-steroid-therapy-…/
For high quality CBD Shifa Oils